Search the web
Sign In
New User? Sign Up
RHODE_ISLAND_FIBROMYALGIA-CFS_SUPPORT · Rhode Island Fibromyalgia & CFS Support
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Hear how Yahoo! Groups has changed the lives of others. Take me there.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
Fibromyalgia   Message List  
Reply | Forward Message #1461 of 1563 |

Fibromyalgia Community Update

 

Friday, January 30, 2009

 

1. New FDA Approval: The U.S. Food and Drug Administration has approved Savella™ (milnacipran) for the management of fibromyalgia. The medication has demonstrated significant improvements in multiple aspects of fibromyalgia, including pain, patient global assessment and physical function. Savella is the third FDA-approved drug for the treatment of fibromyalgia. The FDA approved Lyrica (pregabalin) in June 2007 and Cymbalta (duloxetine HCl) was approved in June 2008. Click here for details.

 

2. It’s FREE to Join! Fibromyalgia Social Network Forum: Send your questions to Randy about the unique challenges faced by men with fibromyalgia; let Jan know about any fibromyalgia-friendly diets that you have tried; chat with Phyllis about your experience with alternative therapies; or start your own dialogue with others. The NFA now offers direct access to an online fibromyalgia community. Click here to learn more

 

3. Reactions to New Membership Program: Hundreds of individuals have signed-up for the NFA’s new online membership program. Thank you for your support! For those who still have questions or concerns about the program, click here.

 

4. FM Healthcare Professionals Honored: Click here for an announcement on the winners of the “Helping Hands: Making a Difference in Fibromyalgia” Awards.

 

5. Getting Ready to Move? Sherri Blackinton, of Arizona, shares her experience with moving and adjusting to a new neighborhood while simultaneously trying to manage her fibromyalgia symptoms. Click here to read our newest Member Spotlight.

 

6. Physician Education: More than 250 healthcare professionals have registered/participated in the Fibromyalgia Assessment, Management and Education (FAME) Project, an online continuing medical education program developed by the National Fibromyalgia Association and California State University, Fullerton. The program, which provides healthcare professionals with accurate fibromyalgia information, recently received accreditation from Commission on Fibromyalgia Community UpdateRehabilitation Counselors Certification. In all, the program has been approved for CME/CE credits by seven highly regarded organizations, including the American Academy of Family Physicians.

 

National Fibromyalgia Association | Unsubscribe

National Fibromyalgia Association Logo

National Fibromyalgia Association. A non-profit 501 (C)(3) organization
2121 S. Towne Centre Place, Suite 300, Anaheim, Ca. 92806 714.921.0150
Copyright ©1997-2007 National Fibromyalgia Association (NFA) All rights reserved.

 
~*Kerrie*~
 
Owner: Rhode Island Fibromyalgia-CFS Support Group on Yahoo
Click the link to join or just to check out the group! New members welcome! This group is for ANYONE with Fibromyalgia/CFS, you do NOT have to be from Rhode Island to join!!!
http://health.groups.yahoo.com/group/RHODE_ISLAND_FIBROMYALGIA-CFS_SUPPORT/
 
 
We are here to do good, help others, then shut up and GO HOME!
--Sylvia Browne
www.sylvia.org


Sun Feb 1, 2009 5:33 pm

blu_bedroom_...
Online Now Online Now
Send Email Send Email

Forward
Message #1461 of 1563 |
Expand Messages Author Sort by Date

National Fibromyalgia Association Friday, January 30, 2009 1. New FDA Approval: The U.S. Food and Drug Administration has approved SavellaT (milnacipran) for...
Kerrie Murray
blu_bedroom_...
Online Now Send Email
Feb 1, 2009
5:34 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help